Thevebioside (an active ingredient from Traditional Chinese Medicine) was reported to inhibit the tumor growth of NSCLC through inhibiting SRC-3–mediated IGF-1R–PI3K-AKT signaling via ubiquitination to induce cellular apoptosis (Yao et al., 2020). The gene discussed is IGF1R; the disease is non-small cell lung carcinoma.